Skip to main content
MAHA® Action
Legislative TrackerMedia HubMAHA WinsMAHA ReportAboutShop
Search
legislative tracker

Legislative Tracker: Track, Advocate & Influence Policy

Track billsView all bills
Featured
Other Great OrganizationsFind other great organizations working alongside us
The MAHA ReportRead the latest MAHA Report and stay informed on all things MAHA™
VolunteerVolunteer your time to help us achieve our mission
Learn More
Contact UsFAQInternshipsSpeaker SubmissionVolunteerEndorsements
Other
Become a MemberSubmit a WinAdd OrganizationRegister to votePrivacy PolicyTerms of Service
SearchSign UpSign InDonate
HomeAboutLegislative TrackerContactVolunteerInternshipsDisinfo DozenAdd OrganizationBecome a Member

Get in on the action

Get updates in your inbox, right as they happen. No waiting, just info right to you.

Instagram
Facebook
X
YouTube

Privacy Policy  |  Terms of Service | 

© 2026 MAHA Action. All rights reserved.

MAHA® Action

“Make America Healthy Again®”

MAHA Action exists to revive and empower a healthier America, free of corporate interests, for the health and prosperity of our communities and country.

Legislative TrackerBillsGeorgia
2025_26
SB 440

Georgia Bill: SB 440

OTC Reform

Topics

Health Freedom

Bill Information

MAHA Approved

Summary

Bill Summary

GA SB 440 is an omnibus public‑health and insurance bill that, among many structural and reporting changes, creates a specific exception allowing ivermectin to be dispensed without a prior prescription under pharmacist supervision. The bill revises Georgia’s “dangerous drug” statute so ivermectin remains classified as a dangerous drug generally, but is exempt when dispensed by a pharmacist to an adult 18 or older after a good‑faith assessment that screens for contraindications, checks current medications for interactions, and does not involve self‑service. Under this exception, the State Board of Pharmacy must adopt rules governing how pharmacists assess patients and dispense ivermectin, effectively making it an over‑the‑counter–style medication available directly from pharmacists while preserving counseling and safety checks. Other provisions in the bill update Department of Public Health duties, shift some program responsibilities, standardize insurer credentialing, and create a mental‑health parity review panel.


Why It Matter to MAHA

The Make America Healthy Again Movement supports GA SB 440 because it expands convenient, lower‑barrier access to human‑use ivermectin by allowing adults to obtain it directly from pharmacists without a doctor’s prescription, under defined safety protocols. MAHA views pharmacist‑mediated, over‑the‑counter–style access as preferable to people self‑dosing with veterinary formulations or going without treatment, and supports giving patients more autonomy to access this long‑standing anti‑parasitic medicine while still benefiting from professional guidance on dosing and interactions. This support is based solely on the ivermectin access provisions and not on any other policy changes contained in the bill.


Introduced

In Committee

03/20/2026

Passed

04/02/2026

Sponsors

Kay Kirkpatrick

Kay Kirkpatrick

Republican Senator (GA)

404-656-0508kay.kirkpatrick@senate.ga.gov
Bo Hatchett

Bo Hatchett

Republican Senator (GA)

404-656-7454bo.hatchett@senate.ga.gov
Ben Watson

Ben Watson

Republican Senator (GA)

404-656-7880ben.watson@house.ga.gov
Drew Echols

Drew Echols

Republican Senator (GA)

404-463-3931drew.echols@senate.ga.gov

Activity

01/29/2026

Senate Hopper

02/02/2026

Senate Read and Referred

02/12/2026

Senate Committee Favorably Reported

02/17/2026

Senate Read Second Time

02/20/2026

Senate Third Read

02/20/2026

Senate Passed/Adopted As Amended

02/24/2026

House First Readers

02/25/2026

House Second Readers

03/06/2026

House Committee Favorably Reported

03/18/2026

House Withdrawn, Recommitted

03/20/2026

House Committee Favorably Reported By Substitute

04/02/2026

House Third Readers

04/02/2026

House Passed/Adopted By Substitute

Questions or suggestions?

Have questions about this bill or our legislative tracker? We'd love to hear from you. Contact us and we'll get back to you as soon as possible.
Contact us